RSC Biological and Medicinal Chemistry Sector and SCI Fine Chemicals Group are holding the 8th meeting in the series on GPCR drug discovery, which will combine cutting-edge medicinal chemistry with innovative structural biology and novel drug design approaches. Our 3decision scientific business developer Elisa Martino will join the event among other participants from pharma and academia.
“The exciting 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry is back in real life this year in Verona. I am happy to be there to learn about the latest innovations in GPCRs discovery and network with everyone. Let’s meet!”
— Elisa Martino, Scientific Business Developer, Discngine
